The KalaCORE consortium has been formed from four organisations, namely Drugs for Neglected Diseases Initiative (DNDi), the London School of Hygiene & Tropical Medicine (LSHTM), Médecins Sans Frontières (MSF), and Mott MacDonald. Each of these organisations brings distinct and complementary skills to delivery of the programme.
KalaCORE aims to make significant contributions to reducing the health and economic impact of VL, by supporting progress towards elimination in South Asia and building stronger capacity for an effective VL response in East Africa.
In South Asia (India, Bangladesh and Nepal), we provide intensive support for strengthening treatment access, with targets of at least 50 treatment centres meeting quality criteria and 80% of service providers trained in endemic areas of the region; the programme aims to also strengthen vector control, the private sector and community response, and VL surveillance in the region.
In East Africa (Ethiopia, Sudan and South Sudan), we aim to expand access to diagnosis and treatment, with targets of at least 12 treatment centres meeting quality criteria and 80% of service providers trained in endemic areas; the programme also aims to ensure endemic areas are mapped, effective vector control methods are evaluated and scaled-up, with a target of 80% of VL outbreaks in the region to be responded to within four months.